A pharmaceutical company's long-term success depends to a large extent on the research and development of new preparations and on successful innovation. Therefore, a considerable proportion of the company's profits are channeled back into this area.
PRO.MED.CS Praha a.s. has its own research base - the Institute of Experimental Biopharmacy jointly owned by our company and the Czech Academy of Sciences. This institute performs pre-clinical pharmacological, toxicological and pharmacokinetic studies on pharmaceutical substances under Good Laboratory Practice and pre-clinical tests of drug forms. It also organises clinical studies under the requirements of Good Clinical Practice. In addition, the institute performs limited research into pharmaceutical substances and drug forms.